Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ABC
    (9)
  • Antibacterial
    (2)
  • Antibiotic
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • BCRP
    (11)
  • BTK
    (1)
  • P-gp
    (2)
  • PDGFR
    (2)
  • Others
    (11)
Filter
Search Result
Results for "

ABCG2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    39
    TargetMol | Activity
  • Peptide Products
    1
    TargetMol | inventory
  • Natural Products
    5
    TargetMol | natural
  • Isotope Products
    2
    TargetMol | composition
ABCG2-IN-2
T795142559759-59-8
ABCG2-IN-2 is a potent inhibitor of ABCG2, showing favorable oral pharmacokinetic profiles in mice, and is applicable for investigating tumor multidrug resistance (MDR) and erythropoietic protoporphyria (EPP) [1].
  • $1,520
6-8 weeks
Size
QTY
ABCG2-IN-1
T795132559759-40-7
ABCG2-IN-1 (compound K2), an analog of Ko143, is an orally active inhibitor of ABCG2 with an IC50 of 0.13 μM, demonstrating favorable oral pharmacokinetics in mice and showing promise for further research [1].
  • $1,520
6-8 weeks
Size
QTY
Avapritinib
T51091703793-34-3
Avapritinib (BLU-285) is a dual inhibitor targeting the mutant KIT receptor (KIT D816V, IC50: 0.27 nM) and PDGFRα (PDGFRα D842V, IC50: 0.24 nM).
  • $80
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Acridone
T20003578-95-0
Acridone could induce cell apoptosis, inhibited ABCG2 (ATP-binding cassette sub-family G member 2) protein, and adjusted hormone level.
  • $30
In Stock
Size
QTY
Vismodegib
T2590879085-55-9
Vismodegib (GDC-0449) is a hedgehog pathway inhibitor (IC50: 3 nM). It also inhibits P-gp (IC50: 3.0 μM), ABCG2 (IC50: 1.4 μM).
  • $38
In Stock
Size
QTY
TargetMol | Citations Cited
CCTA-1523
T95871616271-41-0In house
CCTA-1523 is an efflux function of ABCG2 inhibitor. CCTA-1523 selectively reverses ABCG2-mediated MDR in cancer cells.
  • $89
In Stock
Size
QTY
TargetMol | Inhibitor Sale
A-803467
T2024944261-79-4
A-803467 is a selective NaV1.8 channel blocker.
  • $29
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
MY-5445
T1616478351-75-4
MY-5445 (N-(3-chlorophenyl)-4-phenylphthalazin-1-amine) is a specific inhibitor of phosphodiesterase type 5 (PDE5). MY-5445 selectively inhibits cGMP PDE (Ki:1.3 μM).
  • $38
In Stock
Size
QTY
TargetMol | Inhibitor Sale
PCI 29732
T4337330786-25-9
PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
KS176
T35811253452-78-6
KS176 is a potent and selective inhibitor of the breast cancer resistance protein (BCRP) multidrug transporter, exhibiting no inhibitory activity against P-gp or MRP1.
  • $29
In Stock
Size
QTY
TargetMol | Inhibitor Sale
YHO-13177
T4595912287-56-0
YHO-13177 is a potent and specific inhibitor of BCRP, which enhances the cytotoxicity of SN-38 in cancer cells without affecting P-glycoprotein–mediated paclitaxel resistance in [MDR1]-transduced human leukemia [K562] cells.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Triclabendazole sulfoxide
T38400100648-13-3
Triclabendazole sulfoxide (TCBZ-SO), a primary plasma metabolite of Triclabendazole, inhibits the membrane transporter ABCG2 BCRP and demonstrates anti-parasite effects.
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Zamicastat
T133831080028-80-3
Zamicastat (BIA 5-1058) is an inhibitor of dopamine β-hydroxylase (DBH) and a concentration-dependent dual inhibitor of P-gp and BCRP, with IC50 values of 73.8 μM and 17.0 μM, respectively.
  • $53
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Ceefourin 1
T8596315702-40-0
Ceefourin 1 is a highly selective multidrug resistance protein 4 (MRP4) inhibitor.
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Sale
6,8-Diprenylnaringenin
TN315068236-11-3
6,8-Diprenylnaringenin (Senegalensin) is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity.
  • $417
Backorder
Size
QTY
NSC636795
T2455266528-28-7
NSC636795 is an ABCG2 transporter function inhibitor.
  • $1,520
6-8 weeks
Size
QTY
CAY10719
T376851942919-63-2
CAY10719 is a selective inhibitor of the breast cancer resistance protein ABCG2 (IC50 = 0.23 μM) with little activity at ABCG1. It has been shown to reverse the ABCG2-mediated resistance toward SN 38 and to inhibit ATPase activity.
  • $213
35 days
Size
QTY
YHO-13351
T133661346753-00-1
YHO-13351 is an ABCG2 inhibitor, an acrylonitrile derivative, that induces sensitization of cancer stem initiating-like side population cells to irinotecan.GSK1702934A can be used to study diabetes.
  • $30
In Stock
Size
QTY
Vismodegib-d7
TMIJ-02772733145-73-6
Vismodegib-d7 is a deuterated compound of Vismodegib. Vismodegib has a CAS number of 879085-55-9. Vismodegib is a hedgehog pathway inhibitor (IC50: 3 nM). It also inhibits P-gp (IC50: 3.0 μM), ABCG2 (IC50: 1.4 μM).
  • Inquiry Price
20 days
Size
QTY
Elacridar
T2657143664-11-3
Elacridar (GG918) (GF120918) is an effective BCRP and P-gp (MDR-1) inhibitor.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Methyl Streptonigrin
T257983398-48-9
Methyl Streptonigrin is an ABCG2 transporter function inhibitor.
  • $4,220
10-14 weeks
Size
QTY
NSC107392
T3374919494-89-4
NSC107392 is a substrate of ABCG2.
  • $1,520
Backorder
Size
QTY
UR-MB108
T733692412461-98-2
UR-MB108 is a potent and selective inhibitor of ABCG2 (BCRP), displaying an IC50 value of 79 nM, and exhibits stability in blood plasma.
  • $1,520
6-8 weeks
Size
QTY
NSC265473
T3375361786-74-1
NSC265473 is an ABCG2 substrate.
  • $1,520
Backorder
Size
QTY
Becatecarin
T36485119673-08-4
Becatecarin is a water-soluble, diethylaminoethyl analog of the antineoplastic antibiotic rebeccamycin. It intercalates into DNA, stabilizing the DNA-topoisomerase complex. This results in the potent catalytic inhibition of both topoisomerases I and II, initiating DNA cleavage and apoptosis. Becatecarin, alone or in combination with other compounds, has anti-cancer as well as myelosuppressive effects in vivo. It is also a transport substrate of the ATP-binding cassette (ABC) transporter ABCG2.
  • $535
35 days
Size
QTY
LL-37(17-32)
T80245717919-61-4
LL-37(17-32) is a biologically active peptide fragment derived from the C-terminal domain of human cathelicidin antimicrobial peptide. This segment reverses ABCG2-mediated multidrug resistance in cancer cell lines, highlighting its potential therapeutic role against drug resistance.
  • Inquiry Price
Size
QTY
Antitumor photosensitizer-4
T79711
Antitumor Photosensitizer-4 (compound 10b), a conjugate of dasatinib and imatinib, serves as a potent tyrosine kinase inhibitor (TKI) targeting ABCG2. This photosensitizer (PS) induces apoptosis and reactive oxygen species (ROS) production, while demonstrating significant phototoxicity against both HepG2 and B16-F10 cells [1].
  • Inquiry Price
Size
QTY
ML230
T161071776055-05-0
ML230 is a selective ATP-binding cassette (ABC) transporter ABCG2 inhibitor. It 36-fold selective for ABCG2 over ABCB1 (EC50s: 0.13 μM and 4.65 μM, respectively).
  • $890
35 days
Size
QTY
Glafenine Hydrochloride
T0055L65513-72-6
Glafenine Hydrochloride is an anti-inflammatory agent.
  • $33
In Stock
Size
QTY
5-Hydroxy-2′,3,4′,7-tetramethoxyflavone
TN712419056-75-8
5-Hydroxy-2′,3,4′,7-tetramethoxyflavone shows weak ABCG2 inhibitory potency with IC50s of 3.27 and 3.89 µM in the Hoechst 33342 and pheophorbide A assays.
  • $195
Backorder
Size
QTY
Vismodegib-d4
TMIJ-0276450990-33-6
Vismodegib-d4 is a deuterated compound of Vismodegib. Vismodegib has a CAS number of 879085-55-9. Vismodegib is a hedgehog pathway inhibitor (IC50: 3 nM). It also inhibits P-gp (IC50: 3.0 μM), ABCG2 (IC50: 1.4 μM).
  • Inquiry Price
20 days
Size
QTY
Estradiol 17-(β-D-Glucuronide) (sodium salt hydrate)
T36807
Estradiol 17-(β-D-glucuronide) (E217G) is an estrogen metabolite formed in the liver and subsequently excreted in bile.1It acts as a substrate of the multidrug resistance protein 2 (MRP2; Km= 75 μM), and through MRP2-mediated transport, functions as a cholestatic agent, decreasing bile flow.1,2In addition to binding to the MRP2 transport site, E217G has been shown to bind to an allosteric site that through positive cooperativity activates its own transportviaMRP2 and the transport of other MRP2 substrates, including the non-cholestatic estrogen metabolite, estradiol 3-(β-D-glucuronide) .2,3E217G has also been reported to be transported by MDR1, MRP1, MRP3, MRP4, MRP7, ABCG2 (a breast cancer resistance protein transporter), and the rat organic anion-transporting polypeptides 1-4.2 1.Loe, D.W., Almquist, K.C., Cole, S.P., et al.ATP-dependent 17β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroidsThe Journal of Biological Chemisty271(16)9683-9689(1996) 2.Gerk, P.M., Li, W., and Vore, M.Estradiol 3-glucuronide is transported by the multidrug resistance-associated protein 2 but does not activate the allosteric site bound by estradiol 17-glucuronideDrug Metabolism and Disposition32(10)1139-1145(2004) 3.Gerk, P.M., Li, W., Megaraj, W., et al.Human multidrug resistance protein 2 transports the therapeutic bile salt tauroursodeoxycholateJournal of Pharmacology and Experimental Therapeutics320(2)893-899(2007)
  • $183
35 days
Size
QTY
Efflux inhibitor-1
T725211776055-29-8
Efflux inhibitor-1 is a pyrazolopyrimidine efflux inhibitor. Efflux inhibitor-1 selectively targets toward ABCG2/BCRP over ABCB1 with IC 50 s of 0.45 μM and 2.17 μM, respectively .
  • $993
6-8 weeks
Size
QTY
KPH2f
T624322760615-09-4
KPH2f, a dual URAT1/GLUT9 inhibitor, demonstrates safety, oral activity, and efficacy, with inhibitory concentrations (IC50s) of 0.24 μM for URAT1 and 9.37 μM for GLUT9. It exhibits minimal effects on OAT1 and ABCG2, with IC50 values of 32.14 μM and 26.74 μM, respectively [1].
  • $1,520
10-14 weeks
Size
QTY
NSC103054
T2588419590-55-7
NSC103054 is an ABCG2 transporter function inhibitor.
  • $1,520
6-8 weeks
Size
QTY
Vorolanib
T84911013920-15-4
Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor.
  • $115
In Stock
Size
QTY
Ko 143
TQ0186461054-93-3
Ko 143 is a selective inhibitor of ATP-binding cassette sub-family G member 2 (ABCG2; BCRP).
  • $39
In Stock
Size
QTY
Tectochrysin
T3S1775520-28-5
1. Tectochrysin (Techtochrysine) has antioxidant effect. 2. Tectochrysin is promising inhibitors for the reversal of ABCG2-mediated drug transport. 3. Tectochrysin leads to apoptotic cell death in NSC-LC cells through activation of DR3 and Fas expression via inhibition of STAT3 phosphorylation.
  • $48
In Stock
Size
QTY
Fumitremorgin C
T15355118974-02-0
Fumitremorgin C (12α-Fumitremorgin C) is a mycotoxin and inhibits ABCG2 BRCP.
  • $530
35 days
Size
QTY